EUVIMEDEUVIMED entdecken
Crossref

PTK2B inhibitor PF-431396 inhibits inflammatory response and apoptosis of ovarian granulosa cells by targeting AKT1 phosphorylation in premature ovarian insufficiency

Yang Wang, Zhimin Chen, Fang You, Jing Sun, Hongyi Yang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Reproductive Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China. Electronic address: fccwangy21@zzu.edu.c…. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Granulosa Cells, Proto-Oncogene Proteins c-akt, Focal Adhesion Kinase 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature ovarian insufficiency (POI) is a female reproductive disorder characterized by impaired ovarian function. Protein tyrosine kinase 2 beta (PTK2B), a non-receptor tyrosine kinase, has been implicated in folliculogenesis, but its role in POI remains unknown. In this study, a rat POI model was established by intraperitoneal injection of cyclophosphamide (Cy) for 14 days. Electroacupuncture (EA) has been elicited to effectively improve ovarian function in POI. Here, mRNA sequencing (mRNA-seq) analysis found that PTK2B expression in ovarian tissues was upregulated by Cy treatment but downregulated by EA. To investigate PTK2B's role, primary rat ovarian granulosa cells (GCs) were co-treated with Cy (250 μM) and a PTK2B inhibitor PF-431396 (10 μM) for 48 h. PF-431396 inhibited Cy-induced inflammatory response and apoptosis in GCs. Further, PTK2B binds to AKT1 in GCs. PF-431396 facilitated AKT1 phosphorylation, and the inhibitory effects of PF-431396 on GC inflammatory response and apoptosis were reversed by an AKT1 inhibitor LY294002. In vivo, rats were given PF-431396 (10 mg/kg/d) by gavage for 7 days following Cy induction for 14 days. Treatment with PF-431396 increased ovarian weight, serum E2, and AMH levels, while decreased FSH and LH levels. Additionally, it could improve Cy-induced ovarian tissue injury, inhibit inflammation and apoptosis, and elevate p-AKT1 level in ovarian tissues. Together, our results unveil that PF-431396, a PTK2B inhibitor, ameliorates ovarian dysfunction in POI through promoting AKT1 phosphorylation, suggesting that PTK2B may be a therapeutic target for POI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Ovarian InsufficiencyGranulosa CellsProto-Oncogene Proteins c-aktFocal Adhesion Kinase 1AnimalsFemaleApoptosisPhosphorylationRats, Sprague-DawleyRatsCyclophosphamideCells, CulturedDisease Models, AnimalHumans

Stichwörter der Autor:innen

AKT1ApoptosisInflammationPF-431396PTK2BPremature ovarian insufficiency

Substanzen

Proto-Oncogene Proteins c-aktCyclophosphamideAkt1 protein, ratFocal Adhesion Kinase 1

Autor:innen und Institutionen

  • Center of Reproductive Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China. Electronic address: fccwangy21@zzu.edu.cn.
  • Department of Obstetrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China.
  • Department of Gynecology, the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, PR China.
  • Center of Reproductive Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China.

Förderung

  • Natural Science Foundation of Henan Province

Zitieren

APA

Wang, Y., Chen, Z., You, F., Sun, J., & Yang, H. (2025). PTK2B inhibitor PF-431396 inhibits inflammatory response and apoptosis of ovarian granulosa cells by targeting AKT1 phosphorylation in premature ovarian insufficiency. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114651

Vancouver

Wang Y, Chen Z, You F, Sun J, Yang H. PTK2B inhibitor PF-431396 inhibits inflammatory response and apoptosis of ovarian granulosa cells by targeting AKT1 phosphorylation in premature ovarian insufficiency. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114651

BibTeX
@article{Wang2025,
  author = {Wang, Yang and Chen, Zhimin and You, Fang and Sun, Jing and Yang, Hongyi},
  title = {PTK2B inhibitor PF-431396 inhibits inflammatory response and apoptosis of ovarian granulosa cells by targeting AKT1 phosphorylation in premature ovarian insufficiency},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114651}
}
Kostenlos starten →